Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
14 /100
LOW RISK
Score updated Oct 13, 2026

TERN — Terns Pharmaceuticals, Inc. Dilution Risk Tracker

Track TERN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TERN — Get alerts when the score changes →

As of October 13, 2026, Terns Pharmaceuticals, Inc. (TERN) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. Terns Pharmaceuticals, Inc. has a market capitalization of $6.12B, 115.52M shares outstanding, 325 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
26
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TERN.
🔔 Track TERN — Get forecast alerts →

Market Data

Market Cap$6.12B
Shares Outstanding115.52M
Float115.12M
Cash$1.02B
Debt$1.03M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore14/100DilutionWatch score record
Shares Outstanding115.52MVerified float table or market cache
Public Float115.12MVerified float table or market cache
Market Cap$6.12BMarket data cache
Cash Runway163.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 40.0% shares (2026Q1 vs prior)
325 institutional holders · 169.75M shares
#1 MORGAN STANLEY 21.98M shares
#2 Avoro Capital Advisors LLC 10.04M shares
#3 BlackRock, Inc. 9.57M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-03-27
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-17
4 INSIDER TRANSACTION 2026-02-18
4 INSIDER TRANSACTION 2026-02-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TERN Dilution Snapshot

Terns Pharmaceuticals, Inc. (TERN) has a DilutionScore of 14/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TERN's DilutionScore has held steady at 14/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202614/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TERN shares outstanding have increased 2.1% from 113.01M (Mar 2026) to 115.41M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 15, 2026115.41M115.12M▲ 0.02%
Apr 01, 2026113.01M115.09M▲ 28.12%
Mar 28, 2026113.01M89.83M▲ 5.41%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TERN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TERN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TERN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TERN
TERN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.